| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4c56c12d195c1e0802a7a9ea228659c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0852e6d52784f9f538f4bca78977609e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-13 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-13 |
| filingDate |
2005-11-30^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c221411a652b887ee95bed8c468d4fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2999662cd76eee721446aacab1b77ce5 |
| publicationDate |
2006-07-27^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2006167114-A1 |
| titleOfInvention |
Treatment of stereotypic, self-injurious and compulsive behaviors in man and animals using antagonists of NMDA receptors |
| abstract |
NMDA receptor antagonists can be used in methods of treatment, for reducing the frequency of stereotypic behaviors in animals and for reducing the frequency of analogous compulsive behaviors in humans, for example, those that have been said to be a manifestation of, or related to, obsessive-compulsive disorder. Of particular interest is the non-competitive NMDA receptor antagonist memantine. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007197651-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008100727-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008100727-A3 |
| priorityDate |
1998-03-09^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |